semaglutide discovery positive effects Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review Inside the discovery of semaglutide

Mil Med Res 7:7

The dual action of Mounjaro on both GIP and GLP-1 receptors may contribute to its potential for greater weight loss compared to Ozempic

These medicationsincluding semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity)are widely prescribed for type 2 diabetes and weight management in the UK

If you have a history of recurrent diverticulitis, your clinician will weigh the benefits of Mounjaro against potential risks on an individual basis, considering alternative treatment options if necessary

Long-term use appears safe based on current evidence, though treatment duration depends on individual health goals and response

Dose groups included 0.5 mg, 1 mg (escalation and maintenance), 4 mg (escalation from 2 mg), 8 mg (escalation from 2 to 4 mg), and 12 mg (escalation from 2 to 4 to 8 mg)